{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:48Z","timestamp":1792787928824,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81902568"],"award-info":[{"award-number":["No. 81902568"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Health Bureau Project","award":["No. 2020CXJQ03"],"award-info":[{"award-number":["No. 2020CXJQ03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Current methods for the early detection and minimal residual disease (MRD) monitoring of urothelial carcinoma (UC) are invasive and\/or possess suboptimal sensitivity. We developed an efficient workflow named urine tumor DNA multidimensional bioinformatic predictor (utLIFE). Using UC-specific mutations and large copy number variations, the utLIFE-UC model was developed on a bladder cancer cohort (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009150) and validated in The Cancer Genome Atlas (TCGA) bladder cancer cohort (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009674) and an upper tract urothelial carcinoma (UTUC) cohort (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200922). The utLIFE-UC model could discriminate 92.8% of UCs with 96.0% specificity and was robustly validated in the BLCA_TCGA and UTUC cohorts. Furthermore, compared to cytology, utLIFE-UC improved the sensitivity of bladder cancer detection (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01). In the MRD cohort, utLIFE-UC could distinguish 100% of patients with residual disease, showing superior sensitivity compared to cytology (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01) and fluorescence in situ hybridization (FISH,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). This study shows that utLIFE-UC can be used to detect UC with high sensitivity and specificity in patients with early-stage cancer or MRD. The utLIFE-UC is a cost-effective, rapid, high-throughput, noninvasive, and promising approach that may reduce the burden of cystoscopy and blind surgery.\n                  <\/jats:p>","DOI":"10.1186\/s12943-023-01729-7","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:09:49Z","timestamp":1675469389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma"],"prefix":"10.1186","volume":"22","author":[{"given":"Kaiwei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunkai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaipeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanbo","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjie","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhisong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,4]]},"reference":[{"issue":"6","key":"1729_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1729_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/01.NPR.0000512251.61454.5c","volume":"42","author":"KB Farling","year":"2017","unstructured":"Farling KB. Bladder cancer: risk factors, diagnosis, and management. Nurs Pract. 2017;42(3):26\u201333.","journal-title":"Nurs Pract"},{"issue":"6","key":"1729_CR3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","volume":"74","author":"MGK Cumberbatch","year":"2018","unstructured":"Cumberbatch MGK, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, et al. Epidemiology of bladder Cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784\u201395.","journal-title":"Eur Urol"},{"issue":"8 Pt 2","key":"1729_CR4","doi-asserted-by":"publisher","first-page":"E304","DOI":"10.1111\/j.1464-410X.2011.10188.x","volume":"108","author":"K Matsumoto","year":"2011","unstructured":"Matsumoto K, Novara G, Gupta A, Margulis V, Walton TJ, Roscigno M, et al. Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study. BJU Int. 2011;108(8 Pt 2):E304\u20139.","journal-title":"BJU Int"},{"issue":"1","key":"1729_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","volume":"79","author":"M Roupr\u00eat","year":"2021","unstructured":"Roupr\u00eat M, Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, et al. European Association of Urology guidelines on upper urinary tract Urothelial carcinoma: 2020 update. Eur Urol. 2021;79(1):62\u201379.","journal-title":"Eur Urol"},{"key":"1729_CR6","doi-asserted-by":"crossref","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, Dominguez Escrig JL, et al. European Association of Urology guidelines on non-muscle-invasive bladder Cancer (ta, T1, and carcinoma in situ). Eur Urol. 2022;81(1):75\u201394.","DOI":"10.1016\/j.eururo.2021.08.010"},{"key":"1729_CR7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2147\/CEOR.S274951","volume":"12","author":"LJ Lee","year":"2020","unstructured":"Lee LJ, Kwon CS, Forsythe A, Mamolo CM, Masters ET, Jacobs IA. Humanistic and economic burden of non-muscle invasive bladder Cancer: results of two systematic literature reviews. Clinicoecon Outcomes Res. 2020;12:693\u2013709.","journal-title":"Clinicoecon Outcomes Res"},{"issue":"3","key":"1729_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0302-2838(02)00006-4","volume":"41","author":"MP Raitanen","year":"2002","unstructured":"Raitanen MP, Aine R, Rintala E, Kallio J, Rajala P, Juusela H, et al. Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis. Eur Urol. 2002;41(3):284\u20139.","journal-title":"Eur Urol"},{"issue":"1","key":"1729_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.urolonc.2020.08.016","volume":"39","author":"K Ng","year":"2021","unstructured":"Ng K, Stenzl A, Sharma A, Vasdev N. Urinary biomarkers in bladder cancer: a review of the current landscape and future directions. Urol Oncol. 2021;39(1):41\u201351.","journal-title":"Urol Oncol"},{"issue":"4","key":"1729_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1158\/2159-8290.CD-18-0825","volume":"9","author":"JC Dudley","year":"2019","unstructured":"Dudley JC, Schroers-Martin J, Lazzareschi DV, Shi WY, Chen SB, Esfahani MS, et al. Detection and surveillance of bladder Cancer using urine tumor DNA. Cancer Discov. 2019;9(4):500\u20139.","journal-title":"Cancer Discov"},{"issue":"4","key":"1729_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4103\/0022-3859.123156","volume":"59","author":"N Wadhwa","year":"2013","unstructured":"Wadhwa N, Mathew BB, Jatawa SK, Tiwari A. Genetic instability in urinary bladder cancer: an evolving hallmark. J Postgrad Med. 2013;59(4):284\u20138.","journal-title":"J Postgrad Med"},{"key":"1729_CR12","doi-asserted-by":"publisher","first-page":"e32143","DOI":"10.7554\/eLife.32143","volume":"7","author":"SU Springer","year":"2018","unstructured":"Springer SU, Chen CH, Rodriguez Pena MDC, Li L, Douville C, Wang Y, et al. Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy. Elife. 2018;7:e32143.","journal-title":"Elife"},{"issue":"8","key":"1729_CR13","doi-asserted-by":"publisher","first-page":"e1003732","DOI":"10.1371\/journal.pmed.1003732","volume":"18","author":"PS Chauhan","year":"2021","unstructured":"Chauhan PS, Chen K, Babbra RK, Feng W, Pejovic N, Nallicheri A, et al. Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: a cohort study. PLoS Med. 2021;18(8):e1003732.","journal-title":"PLoS Med"},{"issue":"6","key":"1729_CR14","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.cell.2018.08.027","volume":"174","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum SF, Cantley LC. The multifaceted role of chromosomal instability in Cancer and its microenvironment. Cell. 2018;174(6):1347\u201360.","journal-title":"Cell"},{"key":"1729_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1109\/ICMeCG.2010.16","volume-title":"2010 International Conference on Management of e-Commerce and e-Government","author":"H Yu","year":"2010","unstructured":"Yu H, Huang X, Hu X, Cai H. A Comparative Study on Data Mining Algorithms for Individual Credit Risk Evaluation. In:  2010 International Conference on Management of e-Commerce and e-Government; 2010. p. 35\u20138."},{"issue":"1","key":"1729_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1373\/clinchem.2019.309633","volume":"66","author":"G Ge","year":"2020","unstructured":"Ge G, Peng D, Guan B, Zhou Y, Gong Y, Shi Y, et al. Urothelial carcinoma detection based on copy number profiles of urinary cell-free DNA by shallow whole-genome sequencing. Clin Chem. 2020;66(1):188\u201398.","journal-title":"Clin Chem"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-023-01729-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-023-01729-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-023-01729-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:10:02Z","timestamp":1675469402000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-023-01729-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,4]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1729"],"URL":"https:\/\/doi.org\/10.1186\/s12943-023-01729-7","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,4]]},"assertion":[{"value":"7 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Ethical Committee of PKUFH, FUSCC, or 2<sup>nd<\/sup>HATMU. Every participant provided his or her written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication was obtained from all the participants involved in our study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"H-N Wang, Z-X Guo, F Ding, T Zhou, W Wang, Y-K Wang, L Liu, J Guo, S-P Zhu, X-H Zhang, S-B Cao, and F Lou are employed by Acornmed Biotechnology Co., Ltd. The other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}